About this trial
The study aims to evaluate the efficacy of a relatively new type of psychotherapy called Lifespan Integration (LI) in patients suffering of complex PTSD
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients diagnosed with complex PTSD
French speaking
first time following an LI type of therapy
psychotropic treatment is allowed
Disqualifiers
no other parallel psychotherapy is accepted (if the patient underwent recently any other type of psychotherapy, a "wash out " period of minimum 4 weeks is required )
no active manic episode at the time of inclusion
no active psychotic episode at the time of inclusion
no chronic psychotic disorder diagnosis
Trial design
Single group
Treatments tested in this trial
Lifespan Integration Therapy (LI)
Behavioralsame as above
Treatment groups
Trial outcomes
Primary outcomes
change of the scores of International Trauma Questionnaire
International Trauma Questionnaire measures subscores of simple and complex PTSD, the score is calculated using an algorithm, a minimum score of 8 for the PTSD simple part and of 8 for PTSD complex part is needed in order to diagnose a complex PTSD; the maximum score for simple PTSD is 16, same for complex PTSD.
Secondary outcomes
Difficulties in Emotion Regulation Scale (DERS) Score
the DERS scale (Gratz and Roemer, 2004) contains 36 Likert Scale questions with scores from 1 to 5; the scale can generate a total score and six underscores (assessing nonacceptance, goals, impulse, awareness, strategies, clarity); in a general population cohort the mean score was of 77.99 (SD= 20.72) for N=260 women and 80.66 (SD= 18.79) for N=97 men
Other outcomes
Rosenberg Self - Esteem Scale (RSES) (Rosenberg, 1965)
RSES is one of the most widely used measures of global self esteem; it contains 10 questions with answers ranging from 0 (poor) to 3 (excellent); five questions are positively worded and five questions are negatively worded. Sinclair and colleagues, 2010 reported a mean score of 22.62 (SD=5.80) in a general population cohort from the US of N=503 individuals
Sponsors and contacts
Click on the lead sponsor to view all of their trials.